0.137

87.93% 0.0641

After Hours: .12 -0.017 -12.41%

Bluejay Diagnostics Inc (BJDX)

Overview News Price History Financials Why BJDX Down? Discussions Forecast Stock Split

Bluejay Diagnostics Inc stock is traded at $0.137, with a volume of 782.75M. It is up +87.93% in the last 24 hours and up +2.09% over the past month. Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

Previous Close:

$0.0729

Open:

$0.0741

24h Volume:

782.75M

Relative Volume:

55.06

Market Cap:

$2.27M

Revenue:

Net Income/Loss:

$-9.40M

P/E Ratio:

-0.013

EPS:

-10.55

Net Cash Flow:

$-8.52M

1W Performance:

+38.66%

1M Performance:

+2.09%

6M Performance:

-96.87%

1Y Performance:

-99.53%

1-Day Range:

$0.0741

$0.249

1-Week Range:

$0.0728

$0.249

52-Week Range:

$0.0728

$31.28

Bluejay Diagnostics Inc Stock (BJDX) Company Profile

Name

Bluejay Diagnostics Inc

Sector

Healthcare (1182)

Industry

Medical Devices (148)

Phone

(978) 631-0152

Address

360 MASSACHUSETTS AVENUE, SUITE 203, ACTON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

BJDX's Discussions on Twitter

Bluejay Diagnostics Inc Stock (BJDX) Latest News

12:22 PM

U.S. Stock market: Bluejay Diagnostics (+105.33%), Zoomcar Holdings (+180.40%), and Verrica Pharmaceuticals(+39.10%) among the most volatile stocks during mid day trading - Business Upturn

12:22 PM

09:06 AM

Does Bluejay Diagnostics Inc (NASDAQ: BJDX) Still Look Hot This Week? - Stocks Register

09:06 AM

Nov 01, 2024

BJDX stock touches 52-week low at $0.08 amid sharp annual decline - Investing.com Australia

Nov 01, 2024

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America - Marketscreener.com

Nov 01, 2024

Buejay Diagnostics, Inc Announces Results from the Primary Analysis of SYMON-I - Marketscreener.com

Nov 01, 2024

Oct 27, 2024

Short Interest in Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Grows By 300.8% - Defense World

Oct 27, 2024

Oct 25, 2024

Bluejay Diagnostics shareholders approve reverse stock split - Investing.com India

Oct 25, 2024

Oct 24, 2024

Bluejay Diagnostics shareholders approve reverse stock split By Investing.com - Investing.com UK

Oct 24, 2024

Oct 19, 2024

Bluejay Diagnostics Inc’s (BJDX) -5.05% Retreat Justifies A Second Look - Stocks Register

Oct 19, 2024

Oct 16, 2024

Bluejay Diagnostics adjusts stockholder meeting quorum By Investing.com - Investing.com South Africa

Oct 16, 2024

Bluejay Diagnostics adjusts stockholder meeting quorum - Investing.com India

Oct 16, 2024

Bluejay Diagnostics stock hits 52-week low at $0.1 - Investing.com

Oct 16, 2024

Bluejay Diagnostics stock hits 52-week low at $0.1 By Investing.com - Investing.com UK

Oct 16, 2024

The Potential Rise in the Price of Bluejay Diagnostics Inc (BJDX) following insiders activity - Knox Daily

Oct 16, 2024

Oct 15, 2024

An analyst sees good growth prospects for Bluejay Diagnostics Inc (BJDX) - SETE News

Oct 15, 2024

Oct 14, 2024